The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction (2012)

Nat Neurosci. 2012 Oct;15(10):1330-5. doi: 10.1038/nn.3202.

DiLeone RJ, Taylor JR, Picciotto MR.

Source

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Abstract

The growing rates of obesity have prompted comparisons between the uncontrolled intake of food and drugs; however, an evaluation of the equivalence of food- and drug-related behaviors requires a thorough understanding of the underlying neural circuits driving each behavior. Although it has been attractive to borrow neurobiological concepts from addiction to explore compulsive food seeking, a more integrated model is needed to understand how food and drugs differ in their ability to drive behavior. In this Review, we will examine the commonalities and differences in the systems-level and behavioral responses to food and to drugs of abuse, with the goal of identifying areas of research that would address gaps in our understanding and ultimately identify new treatments for obesity or drug addiction.

INTRODUCTION

Over the last several decades, the developed world has experienced a surge in obesity, with more than 30% of the United States population currently considered obese, and a much greater proportion considered to be overweight (http://www.cdc.gov/obesity/data/facts.html). The health consequences of obesity are enormous, leading to more than 200,000 premature deaths each year in the United States alone. While the obesity epidemic is thought to have multiple causes, many of these converge to produce excess intake. The inability to control intake is reminiscent of drug addition, and comparisons between the uncontrolled intake of food and drugs have become a predominant1, and somewhat controversial2, component of obesity models. In this review, we will examine the systems-level and behavioral responses to food and drugs of abuse. We will highlight the differences, as well as the commonalities, between the mechanisms driving food intake and drug seeking in order to identify areas of research that could cover gaps in knowledge of both obesity and addiction.

In our view, obesity should be treated as a behavioral problem in that many people want to use self-control to diet and lose weight, but cannot. The distinction between the mechanisms involved in the physiological control of food intake and reward, and those involved in the physio-pathological conditions leading to eating disorders and obesity are not yet understood. The distinction between “normal” and “disease” is not clear in animal models and is also less clear for sub-threshold eating disorders that do not reach clinical diagnosis. This is the case with obesity (is it abnormal or normal to overeat?) and eating disorders, where no well-accepted animal model exists. While caloric need clearly drives food seeking under conditions of scarcity, over-eating when food is ubiquitous is driven by intake of highly palatable foods and continued eating even when metabolic demand has been met. It is this aspect of eating that has been compared most directly to drug addiction; however, in order to understand whether food- and drug-seeking behaviors are equivalent, it is critical to measure food reward and compulsive eating in models that have face-validity for human eating and to define these behaviors more precisely. For example, tests of food intake behavior are often conducted in animals that have been food-restricted, and this may not reflect the neural mechanisms relevant in the overweight condition. In addition, an evaluation of the equivalence in food- and drug-related behaviors requires a thorough understanding of the underlying neural circuits driving each behavior in order to determine whether surface similarities in behavior are indeed related to common mechanisms. Many components of the neural systems contributing to food intake have been identified. These include identification of the molecules, such as the orexigenic and anorexigenic peptides, that contribute to food seeking under different conditions, as well as the neuroanatomical basis for some aspects of these behaviors (reviewed in3–5). Although it has been attractive to borrow neurobiological concepts from addiction to explore compulsive food seeking, important pieces of the story are still missing, and a more integrated vision of the underlying neurobiology is needed to understand how food and drugs differ in their ability to drive behavior.

Circuit-level comparisons between food- and drug-seeking

The decision to eat or not to eat and strategies to obtain food are core elements of survival, and are therefore highly susceptible to selection pressures during evolution. Drug addiction is commonly seen as “hijacking” these natural reward pathways, and this view has informed much of the basic research that compares neural substrates of food and drug reward. We speculate that drugs of abuse engage only a subset of the circuits evolved for behaviors related to seeking the natural rewards essential for survival. That is, food intake is an evolved behavior that engages many integrated body systems and brain circuits. Drug addiction is also complex, but starts with a pharmacological event that triggers downstream pathways that did not evolve to transmit that chemical signal.

Mesolimbic dopamine system

The initial site of action for addictive drugs is predominantly on mesolimbic dopamine circuits6. In contrast, the role of mesolimbic circuits in food intake is more nuanced. Mesolimbic circuits influence many behaviors, including reward prediction7, hedonia,8, reinforcement9, motivation10, and incentive salience11. In contrast to behaviors related to drug addiction, nucleus accumbens dopamine depletion alone does not alter feeding12. Pharmacological blockade of D1 and D2 dopamine receptors in the nucleus accumbens affects motor behavior and has small effects on feeding patterns, but does not reduce the amount of food consumed13. Animals lacking dopamine throughout the brain and body do not eat14,15; however, it is difficult to distinguish effects on movement from those on intake and reinforcement per se. In fact, if food is placed into the mouth of animals lacking dopamine they will show normal sucrose preference, suggesting that animals can have hedonic responses for food in the absence of dopamine16.

Hypothalamus

Although activity in the mesolimbic dopamine system is important for the rewarding and reinforcing properties of drugs of abuse and drives some aspects of food seeking as well, a major difference between food seeking and intake of addictive drugs is that hypothalamic nuclei receive and integrate signals, such as leptin and ghrelin, from peripheral tissues, and coordinate peripheral metabolic need and food seeking17. Whereas activation of VTA to NAc dopamine signaling is necessary for drug self-administration, direct stimulation of NPY/AgRP neurons in the hypothalamus is sufficient to drive food intake, even in the absence of dopamine system activation18. Moreover, vagal feedback from the stomach and intestine has an important influence on brainstem activity, and ultimately food intake and metabolism19. The identification and study of these key signals has contributed greatly to our understanding of food intake and has resulted in models of feeding that incorporate both neural and whole body physiology. In contrast, neural models of drug intake often do not consider how the brain and body interact (although there are some exceptions, such as effects of corticosterone on addiction20). This is an area that deserves more attention in studies of drug addiction, however. Indeed, human studies, particularly studies of smokers, suggest that interoceptive cues are essential for ongoing drug taking behavior21,22. Similarly, we know that peripheral metabolic signals can influence dopamine system function and behavioral responses to both food and drugs of abuse23,24.

Interestingly, hypothalamic nuclei, and particularly the lateral hypothalamus, also affect the rewarding properties of abused drugs25. This leads to the idea that the mesolimbic circuit mediates drug reinforcement, which is modulated by some hypothalamic systems, whereas the hypothalamus mediates food seeking and consumption, which is modulated by the dopaminergic system.

Hypothalamic-peripheral communication

In general, a distinction between drugs and food is most apparent when sensory and gustatory feedback is considered. In particular, gut-derived signals are critical determinants of both behavioral and metabolic responses to food26. This includes direct hormonal signals such as cholecystokinin (CCK) and ghrelin, as well as other physical and hormonal effects conveyed by the vagal nerves to the brainstem. Post-ingestive effects of food intake are also important regulators of food-related behaviors and food is reinforcing when directly infused into the stomach27, suggesting that the digestive system is a key component in modulating food intake.

Consistent with the central role of hypothalamic circuits in driving food intake, the termination of food seeking can also be induced by activation of a specific circuit: the POMC expressing neurons in the arcuate nucleus and the subsequent release of melanocortin peptides, are thought to mediate satiety18. With drugs of abuse, recent work has identified the habenula as a brain area involved in aversion to nicotine28,29. This aversive component of drug response may be responsible for the well-known phenomenon of animals maintaining stable blood levels of drug in self-administration paradigms30. It is interesting that tastants can also become aversive and lead to decreased reward sensitivity when given before drug self-administration31. Finally, drug satiety may also occur via aversive feedback from peripheral homeostatic systems regulating heart rate and blood pressure, or gut systems indicating gastro-intestinal distress32. This highlights the need for further study of brain-periphery interactions in regulation of drug intake. It should be noted that under conditions of extended drug access, animals will escalate their drug intake and this self-regulation is disrupted33. This will be discussed further below.

It is likely that the persistent strong aversion to foods that cause nausea or gastric pain evolved as protection against consumption of toxic agents. One pathway thought to be involved in disgust is the projection from the POMC neurons in the arcuate nucleus to the parabrachial nucleus34. A great deal of work has also implicated the amygdala and brain stem in conditioned taste aversion (the avoidance of a stimulus paired with a noxious tastant)35. Human imaging studies have suggested that disgust is also likely mediated by the brainstem as well as the insular cortex36, providing converging evidence that brain stem nuclei encode information about avoidance of noxious foods. The consequence of the existence of dedicated pathways mediating disgust is that the connection between the periphery, in particular the digestive system, and the brain centers mediating food seeking provide a hard-wired brake on food reward. This connection has been harnessed to provide protection against alcohol consumption, the one addictive drug that is caloric, and is consistent with the consensus among clinicians that the effects of disulfiram (Antabuse) are due to the nausea and other aversive symptoms it causes if alcohol is consumed37. Although the dysphoric effect of antabuse may be akin to the disruption of habitual responding to drug-paired cues following pairing with a noxious tastant, it may also be related to the peripheral connections from the digestive system that are particularly important for alcohol. In contrast, since most drugs of abuse are not ingested, this pathway has no effect on other drug seeking or taking.

Sensory perceptions of food are also key elements of intake, food memory, and the drive to eat38. The sight and smell of food drive anticipatory behavior and motivation to eat. Again, it seems that drugs have co-opted circuits that evolved to connect our behavior to our environment. These sensory components of anticipatory behavior and consumption are also critical in addiction and relapse to drug intake39. Cues associated with drug use become secondary, or conditioned, reinforcers39. As these cues have gained incentive value, similar neural circuits appear to be engaged that are normally triggered by sensory stimuli that predict food reward. An example of this is conditioned potentiation of feeding, in which a cue associated with eating can later increase food intake in a sated state40. This paradigm depends on amygdala-prefontal-striatal circuits that also influence drug-associated conditioned reinforcers40 (cue-driven drug taking will be discussed in more detail below).

While we have emphasized the behavioral control of food intake here to draw analogies with drug addiction, it is clear that metabolic adaptations also have significant effects on body weight. It is notable that most manipulations that affect food intake in one direction also influence metabolism in a complementary fashion. For example, leptin decreases food intake while also increasing metabolic rate (decreased efficiency) leading to reduced weight41. There is no clear equivalent to this dual mode of action in drug addiction, where drug taking or seeking is the relevant measurement. This integration with other physiological systems can make the study of obesity more challenging since motivation to eat is only one component of overall weight control.

Cerebral cortex

Studies of drug addiction have incorporated frontal regions of the brain that have not been incorporated fully into animal models of intake. The prefrontal cortex (PFC) can influence drug reinstatement via interactions with mesolimbic and amygdala systems42. These models are generally consistent with the view that the PFC influences inhibitory control and alterations in limbic cortico-striatal circuitry may be both a vulnerability factor for, and consequence of, addiction43,44; however, rodent studies have shown little effect of PFC lesion on food intake45. It is notable that PFC lesions can also leave addictive behaviors such as self-administration intact46, while impairing drug reinstatement47. The negative data showing little effect of cortical lesions on food intake are in contrast to a key study exploring the role of prefrontal u-opioid receptors in food intake and locomotor behavior48. Infusion of a u-opioid agonist into the PFC increases intake of sweet food. In addition, recent studies have identified molecular changes in the cortex in response to high-fat diets in the cortex, suggesting that neuronal plasticity in cortex may contribute to diet-induced behavioral changes49. Molecular and cellular changes in prefrontal cortex have also been identified in response to diets such as highly palatable food50,51. These studies suggest that the PFC likely has a complex role in modulation of feeding behavior, and it is reasonable to assume that some sets of neurons may drive intake, while others might inhibit the behavior. In addition, future work could focus on a role for the orbitofrontal cortex (OFC) in impulsive or perseverant behaviors related to food intake, since cocaine, sucrose and food can all maintain responding in tasks dependent on the OFC.

Imaging studies in human subjects have also implicated frontal cortical regions in responses to food and control over intake2. For example, the orbitofrontal cortex responds to the odors and flavor of a palatable drink when it is being consumed52. In agreement with these data, patients with frontotemporal dementia demonstrate increased drive to eat, suggesting that loss of cortical control can disinhibit circuits promoting food intake53. This is consistent with the rodent studies described above showing that association of a cue or context with eating during a highly motivated (food-restricted) state, will lead the animal to eat more in a sated state in response to the same cue or context40.

Neuropeptides involved in food- and drug-seeking

The neuropeptide systems regulating food intake and satiety can also modulate behavioral responses to drugs of abuse. The mechanisms subserved by these neuropeptides in food- and drug-related behaviors are distinct, however. While there are some neuropeptides that modulate feeding and drug reward in the same direction, there is another group of neuropeptides that regulate food and drug intake in opposite directions. For example, the neuropeptides galanin54 and neuropeptide Y (NPY)55 both increase food intake, but NPY signaling increases cocaine reward56 whereas galanin signaling decreases cocaine reward57 (Table 1). While there is a consensus that neuropeptides that increase VTA dopamine neuron firing augment responses to drugs and food1, there are clearly additional, more complex, interactions that can overrule this relationship. For example, MC4 activation augments cocaine reward58, likely through increased dopamine signaling in the NAc, but decreases food intake through actions in the paraventricular nucleus of the hypothalamus59. Similar mechanisms are also involved in the ability of nicotine acting through nicotinic acetylcholine receptors (nAChRs) to potentiate conditioned reinforcement for sucrose through nAChRs in the VTA60 and to decrease food intake through activation of nAChRs on POMC neurons in the hypothalamus61.

TABLE 1 

Effects of neuropeptides on food intake and cocaine reward

It is important to note that the conditions under which drug reward or drug seeking and food intake are evaluated may contribute to some of these similarities and differences. There may be differences in the effects of neuropeptides on intake of highly palatable food and chow, or under satiated conditions and in obese animals75. Similarly, there may be differences in the effects of neuropeptides on drug seeking between animals that are drug naïve or drug dependent or are tested in different paradigms, such as conditioned place preference and self-administration57,63. This emphasizes the challenge and importance of studying food and drug intake using parallel, or equivalent, behavioral conditions.

Behavioral comparisons between food- and drug-seeking

In many ways, we have a greater understanding of the detailed neural and behavioral basis of drug intake and seeking than we do of food intake and seeking. Addiction studies often involve detailed analysis of self-administration and reinstatement (relapse) that can model the human condition closely; however, it is notable that most behavioral studies done with drugs of abuse, such as operant studies, have been performed in hungry animals. Nonetheless, there is much less consensus on behavioral models that best capture the factors underlying obesity. That is, behavioral models of food seeking, such as responding on a progressive ratio schedule, may not be face-valid models of human food seeking.

Interestingly, whereas drugs are thought to be very highly reinforcing, rodents are more likely to work for sweet rewards such as sucrose or saccharin, even when not food deprived, than they will for cocaine76. This may reflect a greater susceptibility to seeking of highly palatable foods as compared to drugs of abuse at baseline as a result of differential stimulation of reward circuits by sweet tastants. Although extended access to cocaine increases the reinforcing efficacy of the drug much more than for sweet tastants, rodents are still more likely to work for sucrose or saccharin after chronic exposure to cocaine76. While the neurobiological reasons for these differences are not known, one possibility is that the evolutionary advantage of obtaining sweet and highly caloric foods has resulted in multiple neuronal mechanisms driving seeking of these food rewards, whereas only a subset of these mechanisms are recruited by cocaine. This is speculative, however, and must be investigated in more detail via human imaging studies as well as animal models.

Repeated administration of sugar in a binge-like paradigm does increase the locomotor response to an acute administration of amphetamine, however, one behavioral difference between intermittent sugar administration and intermittent administration of drugs of abuse is that there does not appear to be significant locomotor sensitization in response to sugar administration77. Similarly, some studies have shown escalation of drug intake, but not sucrose intake in an extended access paradigm33, although others have shown escalation of a vanilla flavored solution and in other cases, saccharin or sucrose intake78. This suggests that drugs of abuse may be more likely to provoke neuronal plasticity that leads to increased responding over time.

Recent work has applied reinstatement models from drug addiction to studies of food intake79. This is a welcome development that is likely to help extend eating behavior research beyond models of “free-feeding” of chow, and into more specific behaviors with better face validity for human patterns of eating. At the same time, it is not clear if this relapse model captures the neural circuits that are engaged when people attempt to control their food intake. Part of the challenge that is inherent in studies of feeding, unlike drug studies, is the inability to remove all food from the animals. The inability to provide a state of abstinence is a technical challenge, and also reflects the complexities of dieting in human populations. Much recent research has focused on high-fat or sugar foods as the “substance”, but clearly people can gain weight on a variety of diets given the current high rates of obesity.

Despite these caveats and the differences in initial escalation of food and drug intake, increased responding for both drug and a sweet tastant has been observed after increasing withdrawal time (incubation of craving)80. The incubation effect appears to be weaker for sucrose than for cocaine, however, and the increase in responding for sucrose peaks earlier in withdrawal than for cocaine80. In addition, after rodents have learned to self-administer cocaine or sucrose and the response has been extinguished, some studies suggest that stress (unpredictable footshock) can induce reinstatement of responding for cocaine, but not sucrose81, although other studies have shown that stress can lead to food seeking82. This is relevant to the observation in human subjects that acute stress can precipitate binge eating83. Indeed, in rodent models, stress generally results in anorexia and decreased food seeking84–86.

Some of these behavioral disparities may reflect differences in responses to substances that are ingested orally rather than administered through other routes. For example, rodents will approach and bite a lever that is presented with food and will slurp levers non-contingently presented with water, but these responses are not observed for cocaine, perhaps because no physical response is necessary to “ingest” intravenously-delivered drug78.

Another area of difference between food intake and habitual responding for cues related to food, is that although animals and humans can become habitual in their food seeking (they will work for cues that predict food availability even if the food has been paired with an agent that causes gastric distress such as lithium chloride) consumption of that food will decrease although the animals have worked for its delivery87. In addition, the transition from goal-directed to habitual responding occurs more quickly for cues paired with drugs, including alcohol, than for food88. Indeed, goal-directed drug-seeking behavior has been argued to become habitual after prolonged self-administration42,89. Rodents show habitual drug-seeking responding that appears insensitive to devaluation, as shown using ‘chained’ seeking-taking schedules of intravenous cocaine reinforcement. Although this study did not use lithium chloride to devalue cocaine, devaluation of the chained drug seeking-taking link by extinction did not disrupt habitual responding for cues after prolonged access to cocaine90. Recent work with food intake has shown that intake of high fat diets can lead to “compulsive” intake despite negative consequences91, which is another way to test for habitual behavior.

Overall, cues associated with availability of abused drugs result in more reinforcer seeking behavior than food-paired cues after abstinence. Similarly, drug-associated behaviors appear to be more susceptible to stress-induced reinstatement than food-associated behaviors78. Of course, conditioned stimuli associated with drugs are both limited and discrete, and become tightly associated with the interoceptive effects of the drugs that are powerful unconditioned stimuli. In contrast, cues associated with food are multimodal and less salient in terms of their interoceptive effects. Thus, food appears to be a more potent driver of behavior at baseline, whereas drugs of abuse seem to be more able to potentiate the control of behavior by conditioned environmental stimuli. Taken together, it has been suggested that cues that predict cocaine availability promote drug seeking more persistently than cues that predict availability of palatable tastants such as sucrose; thus, palatable foods may begin as relatively strong reinforcers compared to drugs of abuse, but the important factor in development of addictive behavior may be that cocaine and other drugs can create associations that last longer than associations between stimuli paired with natural reinforcers such as food78.

Conclusions and goals for future work

Comparisons of drug addiction and compulsive food intake leading to obesity must take into account that there is a fundamental difference in modeling a “disease state” (ie: addiction) as compared to a complex physiological response that may lead to later somatic disease. The goal of experiments on feeding is to identify circuits that evolved to respond to food scarcity and to determine what happens with those circuits under conditions of food abundance. In contrast, the goal of experiments on addiction is to model a human disorder that uses particular circuits evolved for a different purpose, and, hopefully, to treat that disorder. Thus, abstinence is not a goal for control of food intake, but abstinence is an important goal of research on drug addiction.

The evolutionary pressures that lead to behaviors essential for survival have shaped feeding circuits to favor ongoing food intake over decreased food intake due to satiety-driven satiation. Similarly, the circuits evolved to protect against ingestion of toxic substances and promote disgust can dominate over the hedonic pathways that drive drug seeking. That said, it is important when considering distinctions between food and drug reward to distinguish between apparent differences based on existing research from unexplored commonalities. Of course, it should also be noted that the acute toxic effects of drugs of abuse are distinct from the long-term consequences of over-consumption of palatable foods that lead to obesity.

There are both advantages and limitations of existing animal models of food intake, food reward and obesity. In many respects, animal models of food intake are representative of key biological and physiological processes regulating hunger and satiety. Further, the molecular and neural pathways underlying food intake appear to be conserved across species92; however, there are unique evolutionary contexts across species with different environmental pressures that result in differences between rodent models and the human condition.

One level of control that warrants further research, and may be different for behaviors related to food and drug intake, is the involvement of cortical activity. For example, the ability of discrete regions of the PFC to regulate self-control over subcortical motivational and hypothalamic circuits is not well-integrated into current animal models of food intake or binge eating. This is a major limitation considering data suggesting that top-down cortical control is critical for human food intake and regulation. In addition, there are excellent models for the integration of how whole-body systems and brain circuits contribute to food intake, but much less is known about how effects of drugs of abuse on peripheral systems contribute to addiction. Finally, there have been several behavioral studies that have used the same conditions to study the effects of food reinforcers and addictive drugs, but many comparisons have been made across studies that use different parameters and conditions to make conclusions about similarities or differences in food- or drug-related responses. Side-by-side comparisons will be necessary to conclude that food reinforcement involves equivalent circuits and molecular substrates to result in behaviors that resemble drug addiction. Many drug self-administration studies have already used food or sucrose intake as a control condition. Reanalysis of these existing “control” experiments may provide more information about the similarities and differences between food- and drug-related reinforcement and reinstatement, although additional naïve or sham conditions may be needed to determine adaptations specific to food.

In conclusion, food “addiction” does not have to be the same as drug addiction to be a major health problem. Moreover, many obese individuals may not show signs of addiction93 as there are likely many behavioral paths to gaining weight. Identifying the parallels as well as the points of divergence between physiological and behavioral regulation of uncontrolled food and drug intake will provide greater possibilities for interventions to combat both obesity and drug addiction.

​ 

Figure 1 

Areas of the brain mediating food intake and drug seeking. Areas that are most critical for food intake are depicted in lighter shades and those areas most critical for drug reward and seeking are depicted in darker shades. Most areas have some influence …

ACKNOWLEDGEMENTS

This work was supported by NIH grants DK076964 (RJD), DA011017, DA015222 (JRT), DA15425 and DA014241 (MRP).

Literature Cited

1. Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nature reviews. Neuroscience. 2011;12:638–651. [PubMed]
2. Ziauddeen H, Farooqi IS, Fletcher PC. Obesity and the brain: how convincing is the addiction model? Nature reviews. Neuroscience. 2012;13:279–286. [PubMed]
3. Baldo BA, Kelley AE. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 2007;191:439–459. [PubMed]
4. Horvath TL, Diano S. The floating blueprint of hypothalamic feeding circuits. Nature reviews. Neuroscience. 2004;5:662–667. [PubMed]
5. van den Pol AN. Weighing the role of hypothalamic feeding neurotransmitters. Neuron. 2003;40:1059–1061. [PubMed]
6. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in pharmacological sciences. 1992;13:177–184. [PubMed]
7. Schultz W. Behavioral dopamine signals. Trends in neurosciences. 2007;30:203–210. 10.1016/j.tins.2007.03.007. [PubMed]
8. Wise RA, Spindler J, Legault L. Major attenuation of food reward with performance-sparing doses of pimozide in the rat. Can J Psychol. 1978;32:77–85. [PubMed]
9. Wise RA. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci. 2006;361:1149–1158. [PMC free article] [PubMed]
10. Wise RA. Dopamine, learning and motivation. Nature reviews. Neuroscience. 2004;5:483, 494. [PubMed]
11. Berridge KC. The debate over dopamine’s role in reward: the case for incentive salience. Psychopharmacology. 2007;191:391–431. [PubMed]
12. Salamone JD, Mahan K, Rogers S. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacology, biochemistry, and behavior. 1993;44:605–610. [PubMed]
13. Baldo BA, Sadeghian K, Basso AM, Kelley AE. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity. Behavioural brain research. 2002;137:165–177. [PubMed]
14. Palmiter RD. Is dopamine a physiologically relevant mediator of feeding behavior? Trends in neurosciences. 2007;30:375–381. 10.1016/j.tins.2007.06.004. [PubMed]
15. Zhou QY, Palmiter RD. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell. 1995;83:1197–1209. [PubMed]
16. Cannon CM, Palmiter RD. Reward without dopamine. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2003;23:10827–10831. [PubMed]
17. Kelley AE, Baldo BA, Pratt WE, Will MJ. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiology & behavior. 2005;86:773–795. [PubMed]
18. Aponte Y, Atasoy D, Sternson SM. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nature neuroscience. 2011;14:351–355. [PMC free article] [PubMed]
19. Schwartz GJ. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition. 2000;16:866–873. [PubMed]
20. Goeders NE. Stress and cocaine addiction. The Journal of pharmacology and experimental therapeutics. 2002;301:785–789. [PubMed]
21. Dar R, Frenk H. Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology (Berl) 2004;173:18–26. [PubMed]
22. Gray MA, Critchley HD. Interoceptive basis to craving. Neuron. 2007;54:183–186. [PMC free article] [PubMed]
23. Hommel JD, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006;51:801–810. [PubMed]
24. Fulton S, et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron. 2006;51:811–822. [PubMed]
25. DiLeone RJ, Georgescu D, Nestler EJ. Lateral hypothalamic neuropeptides in reward and drug addiction. Life sciences. 2003;73:759–768. [PubMed]
26. Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 2001;226:963–977. [PubMed]
27. Ren X, et al. Nutrient selection in the absence of taste receptor signaling. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010;30:8012–8023. [PubMed]
28. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature. 2011;471:597–601. [PMC free article] [PubMed]
29. Frahm S, et al. Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula. Neuron. 2011;70:522–535. [PubMed]
30. Koob GF. In: Psychopharmacology : the fourth generation of progress. Bloom FE, Kupfer DJ, editors. Lippincott Williams & Wilkins; 1995. 2002.
31. Wheeler RA, et al. Cocaine cues drive opposing context-dependent shifts in reward processing and emotional state. Biol Psychiatry. 2011;69:1067–1074. [PMC free article] [PubMed]
32. Wise RA, Kiyatkin EA. Differentiating the rapid actions of cocaine. Nature reviews. Neuroscience. 2011;12:479–484. [PMC free article] [PubMed]
33. Ahmed SH, Koob GF. Transition from moderate to excessive drug intake: change in hedonic set point. Science. 1998;282:298–300. [PubMed]
34. Wu Q, Boyle MP, Palmiter RD. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell. 2009;137:1225–1234. [PMC free article] [PubMed]
35. Yamamoto T. Brain regions responsible for the expression of conditioned taste aversion in rats. Chemical senses. 2007;32:105–109. [PubMed]
36. Stark R, et al. Erotic and disgust-inducing pictures–differences in the hemodynamic responses of the brain. Biological psychology. 2005;70:19–29. [PubMed]
37. Wright C, Moore RD. Disulfiram treatment of alcoholism. The American journal of medicine. 1990;88:647–655. [PubMed]
38. Sorensen LB, Moller P, Flint A, Martens M, Raben A. Effect of sensory perception of foods on appetite and food intake: a review of studies on humans. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 2003;27:1152–1166. [PubMed]
39. Stewart J, de Wit H, Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychological review. 1984;91:251–268. [PubMed]
40. Seymour B. Carry on eating: neural pathways mediating conditioned potentiation of feeding. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006;26:1061–1062. discussion 1062. [PubMed]
41. Singh A, et al. Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:13100–13105. [PMC free article] [PubMed]
42. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature neuroscience. 2005;8:1481–1489. [PubMed]
43. Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011;69:680–694. [PubMed]
44. Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology. 1999;146:373–390. [PubMed]
45. Davidson TL, et al. Contributions of the hippocampus and medial prefrontal cortex to energy and body weight regulation. Hippocampus. 2009;19:235–252. [PMC free article] [PubMed]
46. Grakalic I, Panlilio LV, Quiroz C, Schindler CW. Effects of orbitofrontal cortex lesions on cocaine self-administration. Neuroscience. 2010;165:313–324. [PubMed]
47. Kalivas PW, Volkow N, Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron. 2005;45:647–650. [PubMed]
48. Mena JD, Sadeghian K, Baldo BA. Induction of hyperphagia and carbohydrate intake by mu-opioid receptor stimulation in circumscribed regions of frontal cortex. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2011;31:3249–3260. [PMC free article] [PubMed]
49. Vucetic Z, Kimmel J, Reyes TM. Chronic high-fat diet drives postnatal epigenetic regulation of mu-opioid receptor in the brain. Neuropsychopharmacology. 2011;36:1199–1206. [PMC free article] [PubMed]
50. Guegan T, et al. Operant behavior to obtain palatable food modifies ERK activity in the brain reward circuit. Eur Neuropsychopharmacol. 2012 [PubMed]
51. Guegan T, et al. Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuit. Eur Neuropsychopharmacol. 2012 [PubMed]
52. Small DM, Veldhuizen MG, Felsted J, Mak YE, McGlone F. Separable substrates for anticipatory and consummatory food chemosensation. Neuron. 2008;57:786–797. [PMC free article] [PubMed]
53. Piguet O. Eating disturbance in behavioural-variant frontotemporal dementia. Journal of molecular neuroscience : MN. 2011;45:589–593. [PubMed]
54. Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide’s effects in the brain. Peptides. 1990;11:995–1001. [PubMed]
55. Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proceedings of the National Academy of Sciences of the United States of America. 1985;82:3940–3943. [PMC free article] [PubMed]
56. Maric T, Cantor A, Cuccioletta H, Tobin S, Shalev U. Neuropeptide Y augments cocaine self-administration and cocaine-induced hyperlocomotion in rats. Peptides. 2009;30:721–726. [PubMed]
57. Narasimhaiah R, Kamens HM, Picciotto MR. Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice. Psychopharmacology. 2009;204:95–102. [PMC free article] [PubMed]
58. Hsu R, et al. Blockade of melanocortin transmission inhibits cocaine reward. The European journal of neuroscience. 2005;21:2233–2242. [PMC free article] [PubMed]
59. Benoit SC, et al. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2000;20:3442–3448. [PubMed]
60. Lof E, Olausson P, Stomberg R, Taylor JR, Soderpalm B. Nicotinic acetylcholine receptors are required for the conditioned reinforcing properties of sucrose-associated cues. Psychopharmacology. 2010;212:321–328. [PMC free article] [PubMed]
61. Mineur YS, et al. Nicotine decreases food intake through activation of POMC neurons. Science. 2011;332:1330–1332. [PMC free article] [PubMed]
62. DiLeone RJ, Georgescu D, Nestler EJ. Lateral hypothalamic neuropeptides in reward and drug addiction. Life sciences. 2003;73:759–768. [PubMed]
63. Brabant C, Kuschpel AS, Picciotto MR. Locomotion and self-administration induced by cocaine in 129/OlaHsd mice lacking galanin. Behavioral neuroscience. 2010;124:828–838. [PMC free article] [PubMed]
64. Shalev U, Yap J, Shaham Y. Leptin attenuates acute food deprivation-induced relapse to heroin seeking. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2001;21 RC129. [PubMed]
65. Smith RJ, Tahsili-Fahadan P, Aston-Jones G. Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology. 2010;58:179–184. [PMC free article] [PubMed]
66. Shiraishi T, Oomura Y, Sasaki K, Wayner MJ. Effects of leptin and orexin-A on food intake and feeding related hypothalamic neurons. Physiology & behavior. 2000;71:251–261. [PubMed]
67. Edwards CM, et al. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol. 1999;160:R7–R12. [PubMed]
68. Chung S, et al. The melanin-concentrating hormone system modulates cocaine reward. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:6772–6777. [PMC free article] [PubMed]
69. Boules M, et al. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat. Brain research. 2007;1127:90–98. [PubMed]
70. Richelson E, Boules M, Fredrickson P. Neurotensin agonists: possible drugs for treatment of psychostimulant abuse. Life sciences. 2003;73:679–690. [PubMed]
71. Hunter RG, Kuhar MJ. CART peptides as targets for CNS drug development. Current drug targets. CNS and neurological disorders. 2003;2:201–205. [PubMed]
72. Jerlhag E, Egecioglu E, Dickson SL, Engel JA. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology. 2010;211:415–422. [PMC free article] [PubMed]
73. Abizaid A, et al. Reduced locomotor responses to cocaine in ghrelin-deficient mice. Neuroscience. 2011;192:500–506. [PubMed]
74. Abizaid A, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. The Journal of clinical investigation. 2006;116:3229–3239. [PMC free article] [PubMed]
75. Zhang M, Gosnell BA, Kelley AE. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. The Journal of pharmacology and experimental therapeutics. 1998;285:908–914. [PubMed]
76. Lenoir M, Serre F, Cantin L, Ahmed SH. Intense sweetness surpasses cocaine reward. PloS one. 2007;2:e698. [PMC free article] [PubMed]
77. Avena NM, Hoebel BG. A diet promoting sugar dependency causes behavioral cross-sensitization to a low dose of amphetamine. Neuroscience. 2003;122:17–20. [PubMed]
78. Kearns DN, Gomez-Serrano MA, Tunstall BJ. A review of preclinical research demonstrating that drug and non-drug reinforcers differentially affect behavior. Current drug abuse reviews. 2011;4:261–269. [PMC free article] [PubMed]
79. Pickens CL, et al. Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement model. Psychopharmacology. 2012;221:341–353. [PMC free article] [PubMed]
80. Lu L, Grimm JW, Hope BT, Shaham Y. Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology. 2004;47(Suppl 1):214–226. [PubMed]
81. Ahmed SH, Koob GF. Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology. 1997;132:289–295. [PubMed]
82. Nair SG, Gray SM, Ghitza UE. Role of food type in yohimbine- and pellet-priming-induced reinstatement of food seeking. Physiol Behav. 2006;88:559–566. [PMC free article] [PubMed]
83. Troop NA, Treasure JL. Psychosocial factors in the onset of eating disorders: responses to life-events and difficulties. The British journal of medical psychology. 1997;70(Pt 4):373–385. [PubMed]
84. Blanchard DC, et al. Visible burrow system as a model of chronic social stress: behavioral and neuroendocrine correlates. Psychoneuroendocrinology. 1995;20:117–134. [PubMed]
85. Dulawa SC, Hen R. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neuroscience and biobehavioral reviews. 2005;29:771–783. [PubMed]
86. Smagin GN, Howell LA, Redmann S, Jr, Ryan DH, Harris RB. Prevention of stress-induced weight loss by third ventricle CRF receptor antagonist. Am J Physiol. 1999;276:R1461–R1468. [PubMed]
87. Torregrossa MM, Quinn JJ, Taylor JR. Impulsivity, compulsivity, and habit: the role of orbitofrontal cortex revisited. Biological psychiatry. 2008;63:253–255. [PMC free article] [PubMed]
88. Pierce RC, Vanderschuren LJ. Kicking the habit: the neural basis of ingrained behaviors in cocaine addiction. Neuroscience and biobehavioral reviews. 2010;35:212–219. [PMC free article] [PubMed]
89. Belin D, Everitt BJ. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron. 2008;57:432–441. [PubMed]
90. Zapata A, Minney VL, Shippenberg TS. Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010;30:15457–15463. [PMC free article] [PubMed]
91. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nature Neuroscience. 2010;13:635–641. [PMC free article] [PubMed]
92. Forlano PM, Cone RD. Conserved neurochemical pathways involved in hypothalamic control of energy homeostasis. The Journal of comparative neurology. 2007;505:235–248. [PubMed]
93. Gearhardt AN, Corbin WR, Brownell KD. Food addiction: an examination of the diagnostic criteria for dependence. Journal of addiction medicine. 2009;3:1–7. [PubMed]